Intervest Offices & Warehouses NV
11.2.2021 18:01:39 CET | Globenewswire | Press release
Real estate portfolio € 1.018 million (€ 893 million), growth of 14% or 125 million
Yield: Increase in value due the sharpening of yields in logistics real estate in the Netherlands by 52 bp
EPRA earnings per share: € 1,60 (€ 1,91 2019, resp. € 1,68 excl. the one-off indemnity Medtronic)
EPRA NTA: € 22,40 per share (€ 21,77)
Occupancy rate: 93% (93%)
WALB: 4,0 years (4,3 years)
Limited debt ratio: 43% (39%)
Average interest rate of the financing: 2,0% (2,1%)
Non-withdrawn credit lines: € 150 million
Intended gross dividend per share: € 1,53 at the same level as for 2019
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV23.3.2026 07:30:00 CET | Press release
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
Sampo plc23.3.2026 07:30:00 CET | Press release
Sampo has received approval for its extended Group Partial Internal Model
Basilea Pharmaceutica International Ltd, Allschwil23.3.2026 07:15:00 CET | Press release
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Novartis Pharma AG23.3.2026 07:15:00 CET | Press release
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
CoaguSense, Inc.23.3.2026 07:00:00 CET | Press release
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
